Azalea Therapeutics is enabling precision genome engineering directly inside the body, with an initial focus on creating cancer immunotherapies in vivo
Azalea Therapeutics is enabling precision genome engineering directly inside the body, with an initial focus on creating cancer immunotherapies in vivo. The company uses precision genome editing tools to engineer T cells within the patient, employing Envelope Delivery Vehicles (EDVs) to deliver genetic modifications safely and effectively.
Azalea Therapeutics is enabling precision genome engineering directly inside the body, with an initial focus on creating cancer immunotherapies in vivo
Azalea Therapeutics is enabling precision genome engineering directly inside the body, with an initial focus on creating cancer immunotherapies in vivo. The company uses precision genome editing tools to engineer T cells within the patient, employing Envelope Delivery Vehicles (EDVs) to deliver genetic modifications safely and effectively.